Chargement en cours...
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease worldwide. Despite its high prevalence and rising incidence, there are currently no specific targeted pharmacotherapies approved by the Food and Drug Administration (FDA) for nonalcoholic steatohepatitis (NASH). Cur...
Enregistré dans:
| Publié dans: | J Clin Exp Hepatol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926203/ https://ncbi.nlm.nih.gov/pubmed/31889754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.06.003 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|